Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011
Condition(s):Progressive Supranuclear PalsyLast Updated:February 1, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Progressive Supranuclear PalsyLast Updated:February 1, 2024Recruiting
Condition(s):Progressive Supranuclear PalsyLast Updated:December 15, 2023Recruiting
Condition(s):Mild to Moderate Alzheimer’s DiseaseLast Updated:March 11, 2024Active, not recruiting
Condition(s):Benign Prostatic Hyperplasia (BPH)Last Updated:August 25, 2022Completed
Condition(s):Moderate Alzheimer’s DiseaseLast Updated:March 3, 2022Withdrawn
Condition(s):Alzheimer DiseaseLast Updated:July 9, 2020Completed
Condition(s):Benign Prostatic Hyperplasia (BPH)Last Updated:March 4, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.